Filing Flows › Bausch Health Companies (BHC) › Recalls, complaints & regulation
Bausch Health Companies (BHC): recalls
Bausch Health Companies (BHC) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I).
Latest recalls
- 2024-03-06 · FDA drug · Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for U
Bausch Health Companies' latest quarter
Bausch Health Companies, Q3 2026: revenue $2.9B (+10% year over year), operating margin 33.4%, net earnings $436M, operating cash flow $814M. The chart follows the revenue to costs, profit and cash.
Questions
Has Bausch Health Companies had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.